U.S. robotic surgeon, Dr. David Samadi, treats Canadians in his New York City practice at The Mount Sinai Medical Center
Sex after prostate cancer was the second most difficult thing to deal with for Canadian men who have or had prostate cancer. Even more difficult was maintaining hope, according to a prostate cancer study commissioned by Astellas Pharma Canada, Inc. and conducted online by Leger Marketing in October 2012.
David Samadi , MD, world-renowned prostate cancer treatment expert, welcomes many Canadians to his New York practice. Most arrive seeking his unique SMART (Samadi Modified Advanced Robotic Technique) prostate removal surgery and urgent medical counsel. “With this Canadian study, I’m reminded of what access to quality care and the ability to enjoy sex really mean to men,” says Dr. Samadi. “As a robotic prostate surgeon, I’m dedicated to eliminating cancer and preserving sexual function. While I know those to be critical success factors, this list reminds us that without access to advanced treatment specialists and family support, hope wanes.”
According to the Canadian Cancer Society, prostate cancer is the most common cancer among Canadian men (excluding non-melanoma skin cancer) and statistically they face similar prostate cancer probabilities to American men. The American Cancer Society indicates that 1 in 6 men will be diagnosed with prostate cancer in his lifetime and the Canadian Cancer Society reports that 1 in 7 men with be diagnosed.
In the survey, Canadian men who have had prostate cancer noted the following concerns as most difficult to deal with:
– Maintaining hope;
– Sex after prostate cancer;
– Feelings of embarrassment;
– Impact on loved ones;
– Limited access to new, advanced prostate cancer treatments.
“Sex and quality of life are inextricable for most men,” says Dr. Samadi. “My challenge is to balance pre-surgery expectations, the positive results of SMART robotic surgery, and post-surgery support. There’s a great deal that I can do to help patients maintain a happy sex life after prostate cancer and patient education plays a vital role in reaching that goal.”
As Vice Chairman, Department of Urology and Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center in New York, Dr. Samadi treats Canadian and international men with the same lifetime support as he does his U.S. patients. Working closely with men and their families, Dr. Samadi offers expert prostate cancer consultation and robotic prostate surgery success. Patients in his care have the assurance of his more than 4,000 successful procedures and post-surgery sexual recovery guidance. With proper adherence to post-surgery follow-up, 85 percent of Dr. Samadi’s patients regain sexual potency just 12-24 months after surgery.Press Release